Stock Taper Earnings Per Share (EPS): $4.33, up 10% year-over-year.
Operating Margin: 30%, consistent with the prior year.
Return on Capital: 24%, reflecting strong capital discipline.
Sales: $8.8 billion, an 8% increase year-over-year, flat sequentially.
Operating Profit: $2.6 billion, also up 8% year-over-year.
Operating Cash Flow: $2.2 billion, a 4% increase from the previous year.
Free Cash Flow: $900 million, primarily used for dividends and share repurchases.
Capital Expenditures: $1.3 billion, split between maintenance and project backlog.
Market Performance:
Healthcare sales grew 1% year-over-year, with U.S. home care flat due to policy changes.
Food and beverage sales increased 5%, driven by U.S. beverage demand.
Electronics sales rose 10%, fueled by investments in advanced chip production.
Industrial markets showed growth, particularly in the Americas, but faced challenges in EMEA.
Project Backlog: Ended the quarter at $7.1 billion, with significant investments in ultra-high purity plants.
Acquisitions: Signed nine bolt-on acquisitions in the Americas, enhancing future EPS growth.
Q2 EPS Guidance: Expected in the range of $4.40 to $4.50, representing 8% to 10% growth.
Full Year EPS Guidance: Updated to $17.60 to $17.90, or 7% to 9% growth, with a 1% currency benefit included.
Market Assumptions: Guidance assumes no economic improvement at the midpoint, with potential upside from helium market recovery.
Geopolitical Risks: Ongoing Middle East conflict impacting EMEA volumes and creating uncertainty in industrial demand.
Healthcare Segment: U.S. home care business remains flat due to recent policy changes, affecting growth expectations.
Helium Supply Issues: While Linde is well-positioned, global shortages could impact pricing and availability, with potential delays in securing long-term contracts.
Regional Disparities: EMEA continues to face weak industrial activity, contrasting with stronger performance in the Americas.
Cost Inflation: Rapid cost inflation in March created temporary margin pressures, particularly in Europe.
Margins: Improvement expected in the Americas, but EMEA remains a concern due to weak industrial activity and geopolitical impacts.
Commercial Space: Linde is optimistic about growth in the commercial space sector, with potential for reaching $1.7 billion in sales sooner than previously expected.
Volume Landscape: The Americas show positive trends, while EMEA struggles; APAC remains neutral.
Helium Market Dynamics: Incremental volume opportunities exist through long-term contracts, but pricing adjustments depend on the duration of supply disruptions.
Project Delays: No significant delays in the current project backlog, but potential new projects may face geographic-specific challenges. Overall, Linde's Q1 2026 results reflect solid growth amid a challenging economic backdrop, with cautious optimism for future performance tempered by geopolitical uncertainties and sector-specific challenges.
SOURCE: Q1 2026 EARNINGS CALL TRANSCRIPT